Alejandro Majlis
- Gastroenterology top 0.5%
-
- Gastric Cancer Management and Outcomes 5
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 6
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 3
- Pancreatic and Hepatic Oncology Research 2
- Surgery top 5%
-
- Lymphoma Diagnosis and Treatment 9
-
- Chronic Lymphocytic Leukemia Research 6
-
- CNS Lymphoma Diagnosis and Treatment 3
- Co-authors
- Jaffer A. AjaniVladimir MoiseyenkoEric Van CutsemM FodorYee ChaoSergei TjulandinManuel ConstenlaC. Boni
- Partner nations
- ChileUnited StatesBrazil
In The Last Decade
Alejandro Majlis
19 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Gastroenterology 637
- Pulmonary and Respiratory Medicine 1.9k
- Oncology 1.3k
- Surgery 892
- Pathology and Forensic Medicine 287
Countries citing papers authored by Alejandro Majlis
This map shows the geographic impact of Alejandro Majlis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Majlis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Majlis more than expected).
Fields of papers citing papers by Alejandro Majlis
This network shows the impact of papers produced by Alejandro Majlis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Majlis. The network helps show where Alejandro Majlis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alejandro Majlis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 31 | |
| 2 | 2022 | 2 | |
| 3 | 2021 | 5 | |
| 4 | 2020 | 1 | |
| 5 | 2017 | 16 | |
| 6 | 2013 | 17 | |
| 7 | 2011 | 0 | |
| 8 | 2010 | 17 | |
| 9 | 2007 | 208 | |
| 10 | 2007 | 158 | |
| 11 | Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Groupbreakdown → | 2006 | 1480 |
| 12 | 2005 | 22 | |
| 13 | 2005 | 179 | |
| 14 | 2005 | 59 | |
| 15 | 1999 | 3 | |
| 16 | 1998 | 26 | |
| 17 | 1997 | 100 | |
| 18 | 1996 | 63 | |
| 19 | 1995 | 26 | |
| 20 | [Immunologic study of lymphoproliferative diseases]. | 1992 | 1 |
About Alejandro Majlis
Alejandro Majlis is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology, having authored 20 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), CAR-T cell therapy research (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Gastroenterology (637 citations), Pulmonary and Respiratory Medicine (1.9k citations) and Oncology (1.3k citations). Alejandro Majlis has collaborated with scholars based in Chile, United States and Brazil. Frequent co-authors include Jaffer A. Ajani, Vladimir Moiseyenko, Eric Van Cutsem, M Fodor, Yee Chao, Sergei Tjulandin, Manuel Constenla, C. Boni, Э К Возный and Adriano Rodrigues. Their work appears in journals such as Journal of Clinical Oncology, Blood, Hematological Oncology, Journal of Personalized Medicine and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.